receptors in postnatal intestine. Am J Physiol Gastrointest Liver Physiol 280: G555-G562, 2001.-We aimed to characterize endothelin (ET) receptors in the swine intestinal vasculature and to determine ischemia-reperfusion (I/R) effects on these receptors. Saturation and competitive binding assays were performed on mesenteric artery protein membranes from 1-and 40-day-old animals, both control and those subjected to 1 h of partial ischemia followed by 6 h of reperfusion in vivo. Scatchard analysis of saturation binding with 125 I-labeled ET-1 in membranes from endothelium-denuded (E Ϫ ) vessels revealed that the maximum number of binding sites was greater in younger animals. Competitive 125 I-ET-1 binding was significant for a one-site model with ET-1, ET-3, and sarafotoxin S6c (S6c) in membranes from endothelium-intact (E ϩ ) and E Ϫ vessels in both age groups. The maximum number of ET-1 binding sites was significantly greater in younger animals. In the presence of the ET A receptor antagonist BQ-123, competitive 125 I-ET-1 binding was significant for a one-site model with ET-1 and S6c in membranes from E ϩ vessels in both age groups. The maximum number of ET-1 binding sites was significantly greater in younger animals. After I/R, the maximum number of ET-1 binding sites was unchanged. In the presence of BQ-123, specific binding by ET-1 and S6c was eliminated in both age groups after I/R. These results suggest that both ET receptor populations are expressed to a greater degree in younger animals and I/R significantly affects the ET B receptor. swine; newborn intestine; intestinal circulation physiology A POTENT VASOACTIVE 21-amino-acid peptide, endothelin-1 (ET-1) was first isolated by Yanagisawa et al. (27) from the conditioned medium of cultured porcine aortic endothelial cells. Three isoforms of ET have been described: ET-1, ET-2, and ET-3. ET-1 exerts its effects through the activation of at least two distinct receptor subtypes designated ET A and ET B (1, 9, 18, 23). These seven-transmembrane-spanning, G protein-coupled receptors share similar signal transduction pathways. Thus receptor activation increases intracellular Ca 2ϩ concentration via phospholipase C-mediated production of inositol triphosphate and diacylglycerol (21, 22) . The ET A receptor, located on vascular smooth muscle (VSM), is selective for ET-1 and ET-2, and its activation leads to vasoconstriction (2, 3). The ET B receptor, located on the endothelium and VSM, has equal affinity for all three isopeptides. Activation of the endothelial ET B receptor leads to vasodilation mediated via nitric oxide (NO) production and release (4, 20, 23) . Activation of the VSM ET B receptor causes vasoconstriction.
A POTENT VASOACTIVE 21-amino-acid peptide, endothelin-1 (ET-1) was first isolated by Yanagisawa et al. (27) from the conditioned medium of cultured porcine aortic endothelial cells. Three isoforms of ET have been described: ET-1, ET-2, and ET-3. ET-1 exerts its effects through the activation of at least two distinct receptor subtypes designated ET A and ET B (1, 9, 18, 23) . These seven-transmembrane-spanning, G protein-coupled receptors share similar signal transduction pathways. Thus receptor activation increases intracellular Ca 2ϩ concentration via phospholipase C-mediated production of inositol triphosphate and diacylglycerol (21, 22) . The ET A receptor, located on vascular smooth muscle (VSM), is selective for ET-1 and ET-2, and its activation leads to vasoconstriction (2, 3) . The ET B receptor, located on the endothelium and VSM, has equal affinity for all three isopeptides. Activation of the endothelial ET B receptor leads to vasodilation mediated via nitric oxide (NO) production and release (4, 20, 23) . Activation of the VSM ET B receptor causes vasoconstriction.
The role of ET-1 in regulation of swine intestinal hemodynamics and oxygenation changes during early postnatal life. For example, blockade of ET A receptors increases intestinal oxygen extraction and the capillary filtration coefficient in 3-but not 35-day-old animals, indicating that ET-1 exerts a tonic constrictive effect on precapillary sphincters and hence capillary perfusion in an age-specific fashion (12) . Also, although the dose-response curve for ET-1 in mesenteric artery rings is similar in 3-and 35-day-old animals, pretreatment with the selective ET B antagonist BQ-788 significantly shifts the curve leftward in 3-but not 35-day old animals (13) . Finally, sarafotoxin S6c (S6c), a snake venom peptide that has significant sequence homology to the ET isopeptide family and binds exclusively to the ET B receptor, elicits significantly greater vasodilation in precontracted mesenteric artery rings from younger rather than older animals (13) . Collectively, these observations suggest that the binding affinity or receptor number of the ET A and ET B receptors within the intestinal circulation may be developmentally regulated during early postnatal life.
Further support of this possibility is derived from the response of 3-and 35-day-old intestine to ischemiareperfusion (I/R). Younger animals demonstrate a sustained vasoconstriction after I/R that can be significantly attenuated by prior blockade of ET A receptors; in contrast, older animals display a sustained vasodilation under the same circumstance (13) . Also, mesenteric artery rings exposed to I/R in vivo demonstrate a significant leftward shift in the ET-1 dose-response curve, reminiscent of the effect of selective ET B receptor blockade and, once again, this effect is only present in rings from 3-day-old animals (13) . One interpretation of these observations is that I/R causes a selective ablation of ET B receptors in younger intestine.
Based on these observations, we hypothesized that the number of ET A and ET B receptors are developmentally regulated; specifically, newborn intestine has a greater number of these receptors, particularly the endothelial ET B subtype. To test this hypothesis, saturation and competitive binding assays were carried out on membrane prepared from the mesenteric arteries of 1-and 40-day-old swine, under both control and post-I/R conditions.
METHODS
Care and handling of experimental animals. Studies were conducted using farm-bred swine of either sex. Two age groups were studied: 1 day old (newborn) and 40 day old (weanling). All animals were obtained on the day before use and fasted for 12-18 h before surgery. At the end of the first postnatal month, swine had been removed from the sow, weaned from milk, and placed on a grain-based diet. Although not an adult, the 40-day-old weanling piglet has undergone significant postnatal maturation, particularly from the standpoint of intestinal function (5, 19, 25) . Surgery was carried out under anesthesia with tiletamine HCl-zolazepam HCl (7.5 mg/kg im) and xylazine (5 mg/kg im) and maintained with pentobarbital sodium (5 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 iv); the animals were killed by overdose with pentobarbital sodium (6 mg/kg iv). Animals from each age group were divided into two subgroups. Animals assigned to the experimental group were exposed to I/R in vivo. Control animals underwent an identical surgical procedure with the exception of creation of the mesenteric artery coarctation. The mesenteric artery from each animal was used in the binding assays.
Induction of I/R in vivo. Each animal was anesthetized, an airway was established via a midline tracheotomy, and ventilation was started and adjusted to maintain normal blood gas tensions. The mesenteric artery was isolated by retroperitoneal dissection. In animals undergoing I/R, a mesenteric artery coarctation was created by placing a 3-0 silk ligature around the superior mesenteric artery at its origin from the abdominal aorta. A small piece of vinyl tubing (V5 for 3-dayold animals, V7 for 35-day-old animals; Bolab, Lake Havasu City, AZ) was placed in between the artery and the ligature before tightening. After tightening, the vinyl tubing was removed. This action created a precise degree of coarctation that reduced mesenteric blood flow by ϳ75% in both age groups (13) . The ligature was removed after 1 h and reperfusion allowed for 6 h. Non-I/R animals were treated in an identical way except that the ligature was not tightened.
Membrane preparation. The entire mesenteric artery (E ϩ ) was removed en bloc, snap frozen in liquid nitrogen, and stored at Ϫ80°C until use. In some cases, before freezing, the vessel was opened longitudinally and the endothelial layer removed by gentle scraping of the luminal surface (E Ϫ ). Vessel segments were pulverized to a fine powder within a steel chamber while still frozen at Ϫ80°C. In all cases, great care was taken to keep the membrane preparation cold by performing all the following steps on ice. Powdered vessels were suspended in homogenization buffer (50 mM Tris ⅐ HCl, pH 7.4, 5 mM MgCl 2 , 5 mM EDTA, and 1 mM EGTA) and homogenized with a polytron at maximal setting on ice.
Homogenates were centrifuged at 750 g for 5 min at 4°C between each step, and membrane-containing supernatants were saved and combined for a final centrifugation at 20,000 rpm for 35 min at 4°C to pellet the membranes. Membrane pellets were reconstituted in assay buffer (50 mM HEPES and 5 mM MgCl 2 ) via tituration through a progressive series of 18-, 21-, 23-, and 25-gauge needles. An aliquot of the final membrane preparation was used to assay for total protein with the bicinchoninic acid protein assay (Pierce, Rockford, IL).
Saturation and competition binding assays. A series of preliminary experiments was performed to optimize binding conditions for 125 I-labeled-ET-1. To determine a suitable membrane concentration, increasing amounts of membrane (10-100 g) from E Ϫ vessels were incubated with 125 I-ET-1. From these data, 50 g of protein per sample were chosen for the assays as this concentration was on the linear portion of the membrane concentration vs. maximal 125 I-ET-1 binding curve (data not shown). An incubation time of 2 h at 23°C was selected for the assays because 125 I-ET-1 binding reached equilibrium under these conditions. All binding experiments were carried out in a total volume of 0.5 ml assay buffer (50 mM HEPES, 5 mM MgCl 2 , and 0.3% BSA).
Total 125 I-ET-1 binding was determined in saturation studies by incubating membrane samples (50 g) prepared from E Ϫ vessels with increasing concentrations of 125 I-ET-1 (12.5-200 pmol/l). Nonspecific binding was determined in parallel incubations containing excess unlabeled ET-1 (1 M). After the 2-h incubation period, the assay was halted by the addition of 0.5 ml ice-cold assay buffer to the reaction mixture. Bound and free ligand were separated via centrifugation (1,500 rpm at 4°C for 10 min) followed by aspiration of the free ligand containing supernatant. Pellets were washed once with 1 ml ice-cold 50 mM Tris ⅐ HCl. Final bound ligand containing membrane pellets were counted for 125 I for 2 min in a gamma counter (model 5010, Packard Instrument, Meriden, CT). Specific binding was calculated as the difference between total and nonspecific binding. Nonspecific binding was consistently Ͻ20% of total binding for each separate assay.
Competitive binding experiments were performed in triplicate with membrane (50 g) prepared from E ϩ or E Ϫ vessels and 125 I-ET-1 (33.3 pmol/l) plus decreasing concentrations of unlabeled ET-1 (10
Ϫ6
-10 Ϫ11 M), and S6c (10 Ϫ6 -10 Ϫ11 M) as competitor. S6c is a snake venom peptide with significant sequence homology to the ET isopeptide family; it binds exclusively to the ET B receptor and is therefore a useful ligand to discriminate between ET A and ET B receptors (26) . Nonspecific binding was determined by the addition of 1 M unlabeled competitor. Specific binding was calculated as the difference between total binding and nonspecific binding.
In some cases, pharmacological blockade of the ET A receptor was performed to eliminate ET A binding before carrying out the binding assay to determine the presence of the endothelial ET B receptor. To this end, the nonpeptide ET A receptor antagonist BQ-123 (5 ϫ 10 Ϫ5 M) was added to membrane prepared from E ϩ and E Ϫ vessels and allowed to incubate for 1 h before carrying out competitive binding assays with decreasing concentrations of unlabeled ET-1 (10
-10 Ϫ11 M) and S6c (10 Ϫ6 -10 Ϫ11 M) as competitive ligands (7). The amount of BQ-123 added was five orders of magnitude greater than the dissociation constant (K d ) for the ET A receptor established in preliminary studies (i.e., ET A K d ϳ0.25 nM). After the 2-h incubation period at 23°C, the assay was halted by the addition of 0.5 ml ice-cold assay buffer to the reaction mixture. Bound and free ligand were separated via centrifugation (1,500 rpm at 4°C for 10 min) followed by aspiration of the free ligand containing supernatant. Pellets were washed once with 1 ml ice-cold 50 mM Tris ⅐ HCl. Final bound ligand containing membrane pellets were counted for 125 I for 2 min in a gamma counter (model 5010, Packard Instrument). Specific binding was calculated as the difference between total binding and nonspecific binding. Nonspecific binding was typically 10-20%.
Data analysis.
All observations were made in triplicate, and the average response was determined. In statistical analysis and data presentation, n refers to the number of animals in which observations were made. Data are expressed as means Ϯ SE. Concentrations expressed represent the final concentration in the reaction mixture. K d (in nM) and B max (maximum number of binding sites, in fmol/mg protein) using ET-1 as the competitive ligand were calculated for each membrane sample using the nonlinear curve-fitting RADLIG computer program (11) . Single and multiple site models were statistically compared to determine the best fit by comparing the residual variance using an F test. The model that yielded the greatest degree of significance was chosen. Responses were compared between age groups by a three-way ANOVA, which utilized group (1 vs. 40 day old), condition (control vs. I/R), and drug concentration as the main effects. Post hoc Tukey B tests were carried out on data sets in which the F statistic was significant (P Ͻ 0.01), to determine the sites of significant differences between variables.
RESULTS
Binding studies carried out in membrane prepared from control animals. Specific binding of 125 I-ET-1 to membranes prepared from E Ϫ mesenteric arteries was Table 1 . Data are given as means Ϯ SE; n ϭ 8 for all observations. a saturable process in membranes prepared from both age groups (Fig. 1) . Scatchard analysis of the saturation binding curves generated similar K d values of 0.24 Ϯ 0.05 and 0.16 Ϯ 0.07 nM for 1-and 40-day-old subjects, respectively. The B max was significantly higher in 1-vs. 40-day-old animals (277 Ϯ 104 vs. 29 Ϯ 13 fmol/mg protein, respectively, P Ͻ 0.01).
Membranes prepared from E Ϫ vessels from both age groups demonstrated competition binding data that were best fit by a one-site model (Fig. 2) . The efficacy of displacement of 125 I-ET-1 was ET-1 Ͼ ET-3 Ͼ Ͼ S6c.
This profile is consistent with the isopeptide-selective ET A receptor. The K d values generated using ET-1 as the competitive ligand were similar in both age groups; however, the B max values were significantly greater in membrane prepared from younger animals ( Table 1) . These observations identify the presence of ET A receptors on VSM and further indicate that the number of receptors is significantly greater in membrane prepared from younger animals. A similar pattern emerged in the competitive binding assays carried out on E ϩ vessels. Thus membranes prepared from E ϩ vessels from both age groups demonstrated competition binding data that were best fit by a one-site model (Fig. 3) . The efficacy of displacement of 125 I-ET-1 was ET-1 Ͼ ET-3 Ͼ Ͼ S6c, once again consistent with the isopeptide-selective ET A receptor. The K d values generated using ET-1 as the competitive ligand were similar in both age groups and were also statistically similar to values obtained in E Ϫ vessels. The B max values were significantly greater in membrane prepared from younger animals and were also statistically similar to values obtained in E Ϫ vessels (Table 2) .
To delineate the presence of ET B receptors, E ϩ membranes were first treated with the selective ET A antagonist BQ-123. The concentration of BQ-123 used for blockade (5 ϫ 10 Ϫ5 M) was five orders of magnitude greater than the K d for the ET A receptor, assuring a complete blockade of the ET A receptor population. This blockade reduced total specific binding of E ϩ membranes by 93% in 40-day-old animals, but only by 79% in 1-day-old animals, indicating that the remaining population of ET receptors was greater in younger animals ( Table 2 ). Competitive binding of this residual receptor population revealed an efficacy of displacement of 125 I-ET-1 that was equal for ET-1 and S6c (Fig.   Fig. 3 . Competition binding curves for entire mesenteric artery (E ϩ ) from 1-and 40-day-old control animals. Top: 1-day-old group. Bottom: 40-day-old group. Symbols same as given in Fig. 2 legend. The competitive binding profile is consistent with the isopeptide-selective ET A receptor. The K d and B max values for these binding curves are presented in Table 2 . Data are given as means Ϯ SE; n ϭ 3 for all observations. 4 ). This binding profile is consistent with the ET B receptor, which is nonisopeptide selective. The binding data were best fit by a one-site model, and the K d values generated with ET-1 as the competitive ligand were similar in both age groups (Table 2) . However, the B max values indicated that the number of ET B receptors was significantly greater in membrane prepared from younger animals, consistent with the effect of BQ-123 on total specific binding. This assay was repeated in membrane prepared from E Ϫ vessels from both age groups. Neither group demonstrated specific competitive binding after blockade of the ET A receptors with BQ-123. Collectively, these observations indicate the presence of ET B receptors on the endothelium, but not VSM; furthermore, the number of ET B receptors is significantly greater in membrane prepared from younger animals.
Binding studies carried out in membrane prepared from animals exposed to intestinal I/R in vivo. Membrane prepared from E ϩ vessels exposed to I/R in vivo demonstrated competitive binding profiles similar to those noted under control conditions in both age groups. Thus both age groups demonstrated binding data that were best fit by a one-site model with an efficacy of displacement of 125 I-ET-1 that was ET-1 Ͼ Ͼ S6c, a pattern consistent with the ET A receptor (Fig. 5) . The K d values generated using ET-1 as the competitive ligand were similar in both age groups and were also similar to the values obtained in E ϩ control vessels. Similar to the E ϩ control vessels, the B max values were significantly greater in younger animals ( Table 3 ). These observations indicate that the population of ET A Table 2 . Data are given as means Ϯ SE; n ϭ 3 for all observations.
Fig. 5. Competition binding curves for E
ϩ mesenteric artery from 1-and 40-day-old animals exposed to ischemia-reperfusion (I/R) in vivo. Top: 1-day-old group. Bottom: 40-day-old group. Symbols same as given in Fig. 4 legend. Note that the competition is greater for ET-1 than for S6c, a pattern consistent with the isopeptide-selective ET A receptor. The K d and B max data for these curves are presented in Table 3 . Data are given as means Ϯ SE; n ϭ 3 for all observations . Values are means Ϯ SE; n ϭ 3 for all observations. The ischemiareperfusion (I/R) data represent the K d and B max values for the isopeptide-selective ET A receptor as the competition pattern was ET-1 ӷ S6c. * P Ͻ 0.01 vs. 1-day-old I/R. receptors was not affected by the perturbation of I/R in either age group.
Blockade of the ET A receptor population with BQ-123 was also carried out in membrane prepared from mesenteric artery exposed to I/R in vivo. In younger animals, specific competitive binding with ET-1 or S6c was eliminated by in vivo exposure of the mesenteric artery to I/R (Figs. 6 and 7) . The RADLIG program would not generate K d or B max values for these binding data because of the lack of specific binding for ET-1. These observations indicate that the endothelial ET B population was essentially eliminated by the perturbation of I/R in mesenteric artery from 1-day-old animals. In contrast to the younger age group, membrane prepared from mesenteric artery from 40-day-old animals exposed to intestinal I/R demonstrated competitive binding data similar to that noted in control animals (Figs. 6 and 7) .
DISCUSSION
Data from these experiments support the working hypothesis, i.e., the presence of ET A and ET B receptors within the postnatal intestinal circulation is developmentally regulated. Both age groups demonstrated a receptor whose ligand binding profile was consistent with the ET A receptor, and these receptors were located on VSM; however, the number of VSM ET A receptors was significantly greater in mesenteric artery harvested from 1-than 40-day-old animals (1) (2) (3) 9) . Blockade of the ET A receptor population with BQ-123 uncovered a second receptor whose ligand profile identified it as the ET B receptor (18, 20) . This receptor was localized to the endothelium in both age groups; however, older animals demonstrated a marked paucity of the ET B receptor compared with the 1-day-old group. Thus mesenteric artery from 1-day-old animals contains VSM-based ET A receptors and, especially, endothelial-based ET B receptors in a substantially greater quantity than from 40-day-old animals. ϩ mesenteric artery exposed to I/R in vivo in membrane pretreated with BQ-123. One-day-old animals were exposed to I/R in vivo; thereafter, membrane was prepared for binding assays. BQ-123 was administered to the membrane before carrying out the binding assay to block the ET A receptors, so that the competitive binding data shown here represents the residual ET B receptor population. Top: curves generated using ET-1 (E) as the competitive ligand. Bottom: curves generated using S6c (ᮀ) as the competitive ligand. Top and bottom: control data are shown for comparison with post-I/R data ({); these control data are identical to those presented in Fig. 4 . Note the loss of specific competitive binding in membrane prepared from mesenteric artery exposed to I/R in vivo. The RADLIG program was unable to generate K d and B max data from the I/R binding data. These observations indicate a substantial loss of the ET B receptor population after I/R. Data are given as means Ϯ SE; n ϭ 3 for all observations. ϩ mesenteric artery exposed to I/R in vivo in membrane pretreated with BQ-123. Forty-day-old animals were exposed to I/R in vivo; thereafter, membrane was prepared for binding assays. BQ-123 was administered to the membrane before carrying out the binding assay to block the ET A receptors, so that the competitive binding data shown here represents the residual ET B receptor population. Top: curves generated using ET-1 (F) as the competitive ligand. Bottom: curves generated using S6c (s) as the competitive ligand. Top and bottom: control data are shown for comparison with post-I/R data (}); these control data are identical to those presented in Fig. 4 . Data are given as means Ϯ SE; n ϭ 3 for all observations. These receptor binding data correlate well with our (12, 13) prior observations regarding the hemodynamic effects of ET-1 in the postnatal intestinal circulation. For example, the contractile response of mesenteric artery rings to exogenous ET-1 is similar in both age groups; however, only rings from younger animals demonstrate a significant leftward shift of the ET-1 dose-response curve after selective blockade of the ET B receptors with BQ-788 or mechanical removal of the endothelium. Similarly, administration of exogenous ET-1 to in vivo gut loops leads to a greater rise in intestinal vascular resistance in younger but not older animals after pretreatment with BQ-788 (8) . Also, S6c, a selective ET B receptor agonist (26) , causes a far greater degree of dilation in precontracted mesenteric artery rings from younger animals. These hemodynamic effects are entirely consistent with the binding data presented in this report; thus a large population of endothelium-based, dilatory ET B receptors would counterbalance the constrictor effects generated by the ET A receptor. Activation of the ET B receptor leads to a brisk rise in intracellular Ca 2ϩ concentration within the endothelial cell via the phospholipase C-inositol triphosphate-diacylglycerol signal transduction pathway (21, 22) , which in turn stimulates the endothelial isoform of NO synthase (4, 20, 23) . Activation of endothelial ET B receptors would therefore generate the dilatory agent NO. It is interesting that the significantly greater number of ET A receptors in 1-day-old intestine is neatly counterbalanced by a far greater population of ET B receptors at this postnatal age, i.e., that developmental regulation of both receptors occurs so as to maintain a relative hemodynamic balance of the constrictor and dilator actions of ET-1.
Why are there so many ET A receptors present in 1-day-old mesenteric artery? It is not logical to expect that their presence relates to resistance regulation for at least two reasons. First, intestinal vascular resistance is significantly lower in 1-than 40-day-old swine intestine, not higher as one might expect in the presence of an exceptionally large number of contractile ET A receptors (15) . Second, blockade of ET A receptors with BQ-610 under in vivo conditions has little effect on intestinal vascular resistance when hemodynamic conditions are normal (12) . However, the role of the ET A receptor significantly transcends that of hemodynamic regulation; indeed, one of its primary functions is to facilitate angiogenesis and vascular remodeling (6, 16, 17) . We speculate that the abundance of ET receptors in newborn intestine reflects this angiogenic role. The intestinal mass increases dramatically in swine during the first postnatal month with respect to overall body growth (25) ; thus the intestinal mass is ϳ80 g in a total body wt of ϳ1.5 kg on the first postnatal day (ratio: 0.053) and 600 g in a total body wt of 4 kg by the end of the first postnatal month (ratio: 0.15). This rapid rate of growth necessitates the generation of new vasculature. The substantial presence of endothelial ET B receptors permits the existence of relatively large amounts of ET-1 within the newborn intestine (12) without causing overwhelming vasoconstriction.
The data from these experiments also permit a more detailed interpretation of the age-dependent hemodynamic effects of I/R previously reported by Nowicki (14) from this laboratory. Partial ischemia for 1 h followed by 2 h of reperfusion leads to a sustained vasoconstriction in newborn animals (14) . Here we observed a selective loss of the endothelial ET B receptor population in 1-day-old mesenteric artery after a similar I/R insult, whereas the ET A receptor population was unaffected. Loss of the dilatory ET B receptor population would upset the balance normally present between the ET A and ET B receptors, favoring constriction. These events at the receptor level would explain the development of sustained constriction after I/R in newborn intestine. In this context, Luscher (10) and Vanhoutte and Shimokawa (24) have demonstrated that the perturbation of I/R within the coronary circulation selectively attenuates endothelial cell function, leaving VSM function intact and causing an imbalance between locally generated constrictor and dilator forces. These reports are not specific for ET receptors, but do highlight a similar pattern demonstrated (14) in the newborn intestinal circulation, i.e., selective I/R-induced damage to the endothelium, leading to a relative loss of endothelium-derived dilatory forces.
We conclude that the ET receptor population in postnatal mesenteric artery is age dependent, thus 1-dayold animals have a significantly greater population of ET A and ET B receptors than do older animals. Furthermore, we conclude that the effect of partial I/R on the ET receptor population is receptor dependent, thus the ET B receptor population is selectively ablated by partial I/R whereas the ET A receptor is relatively unaffected.
